Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ELIPHOS® Tablets safely and effectively. See full prescribing information for ELIPHOS® Tablets. ELIPHOS® Tablets (calcium acetate): 667 mg Initial U.S. Approval: 1990
Medication labelWhy this: Advisory · dailymed-prescription
ELIPHOS® is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD).
- generic_name
- calcium acetate
- product_names
- Calcium Acetate
- ndc
- 68151-5204, 63717-910, 68151-5204-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en